Search
The Partnership for Safe Medicines is pleased to announce the keynote speaker for Interchange 2014 on September 18, in Washington DC: Howard Sklamberg, Deputy Commissioner for the FDA’s Global Regulatory Operations and Policy. Deputy Commissioner Sklamberg directs the Office of Regulatory Affairs and the Office of International Programs. He oversees the FDA’s efforts to supervise international product quality and safety,…
Read MoreThis is a reprint of an FDA Alert Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Contact Consumer: 719-235-8864 Media: 719-235-8864 FOR IMMEDIATE RELEASE – March…
Read MoreIn his op-ed featured in The Hill on March 1, 2014, LaGanga anticipated that the recent hearing Counterfeit Drugs, Fighting Illegal Supply Chains will spark new efforts by the government to educate patients and take stronger action to stop this growing health threat. He encouraged policymakers to better understand the real nature of the threats posed counterfeit drugs, and cited several…
Read MorePhoto Credit: Pfizer Corporation. Decision by European Parliament gives front-line customs agents the power to seize suspected counterfeit medications that cross their border even if they are in transit to a different country. The European Parliament passed a draft law making it easier for customs authorities to intercept counterfeit medications that pass in transit between European Union member nations. Currently,…
Read MoreWashington, D.C. (February 27, 2014) – Marv Shepherd, President of the Partnership for Safe Medicines (PSM), released the following statement on today’s hearing on counterfeit medicines held by the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations. The hearing, titled “Counterfeit Drugs: Fighting Illegal Supply Chains” brought to light some disturbing trends that must be addressed in order to…
Read MoreIn Online Availability And Safety Of Drugs In Shortage: A Descriptive Study Of Internet Vendor Characteristics, Dr. Tim Mackey and Dr. Bryan Liang examined how Internet pharmaceutical vendors take advantage of known drug shortages to market unapproved and unsafe versions of these medications directly to consumers. Find out why drug shortages play into the hands of drug counterfeiters and black…
Read MoreBlack market medicine distributors have impacted patient health in many areas. We examined two different therapeutic areas of non-FDA approved medication infiltrating the secure U.S. drug supply chain. Learn more about the prescription drug black market and what policy makers, medical professionals, patients and consumers can do to protect the secure U.S. drug supply chain. Black Market Cancer Drug Cases…
Read MoreTake a moment to peruse “Are Tier One Countries Safe to Import Medicine From?” and teach yourself about the true dangers inherent in medicine importation. The Partnership for Safe Medicines answers the question of drug importation safety with a resource designed to make clear the real costs you incur when you purchase non-FDA approved medications from overseas. Learn more about medicine…
Read MoreThe Partnership has released a new version of this publication. Please consult the 2017 edition here. Download and read Counterfeit Drugs: A dangerous threat to American patients. This resource developed by The Partnership for Safe Medicines explains the counterfeit medicines issues as they impact the U.S. Explaining the breadth of the problem, it then details the ways that Americans have been…
Read MoreHere is SAFEMEDICINES’ list of materials for policy makers who want to learn more about counterfeit medications in the United States. How do these criminals operate? How are they brought to justice? Watch this SAFEMEDICINES video where two experienced prosecutors from the US Department of Justice delve…
Read More